Loading…
Transchem (BSE 500422)₹417.50−0.38%Pharmaceuticals
Transchem is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 119.3 against a peer median of 26.7. By market cap it is #3 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Valiant Laboratories | 605 | 37.7 | 1.0 | −1.2 | 0.15 | 0.0 | 237 | −3 | 145.0 | 945.3 | vs BSE 500422 |
| Influx Healthtech | 587 | 28.5 | 40.1 | 30.0 | 0.00 | 0.0 | 147 | 21 | 40.3 | 37.4 | vs BSE 500422 |
| Transchem | 509 | 119.3 | — | — | 0.00 | 0.0 | 0 | 4 | — | 204.5 | — |
| Trident Lifeline | 505 | 22.3 | 21.0 | 22.6 | 0.73 | 0.1 | 129 | 19 | 50.4 | 29.5 | vs BSE 500422 |
| KRM Ayurveda | 495 | 24.5 | 35.0 | 29.0 | 0.00 | 0.0 | 102 | 20 | 31.0 | 123.8 | vs BSE 500422 |
| Albert David | 457 | 20.2 | 1.0 | −0.4 | 0.08 | 0.6 | 333 | −1 | 42.3 | 300.6 | vs BSE 500422 |
| Infinium Pharmachem | 421 | 34.5 | 13.0 | 10.6 | 0.00 | 0.0 | 189 | 14 | 45.2 | 166.1 | vs BSE 500422 |
| HALEOS LABS | 421 | 26.7 | 10.0 | 8.4 | 0.52 | 0.1 | 333 | 18 | −11.6 | −58.2 | vs BSE 500422 |
| Jenburkt Pharmaceuticals | 420 | 12.8 | 27.0 | 20.2 | 0.01 | 2.2 | 169 | 35 | −0.2 | −24.4 | vs BSE 500422 |
| Jenburkt Pharmaceuticals | 417 | 12.7 | 27.0 | 20.3 | 0.01 | 1.9 | 169 | 35 | 0.0 | −24.4 | vs BSE 500422 |
| Medicamen Biotech | 379 | 34.8 | 5.0 | 4.0 | 0.17 | 0.4 | 197 | 10 | 11.3 | 15.7 | vs BSE 500422 |
| Peer median | 457 | 26.7 | 17.0 | 15.4 | 0.01 | 0.1 | 169 | 18 | 35.6 | 37.4 |
Listed companies closest to Transchem in Pharmaceuticals include Valiant Laboratories, Influx Healthtech, Trident Lifeline, KRM Ayurveda, Albert David, Infinium Pharmachem, HALEOS LABS, Jenburkt Pharmaceuticals.
Valiant Laboratories, with a market cap of ₹605 Cr.
Transchem trades at a P/E of 119.3; the median of its peer set is 26.7. A P/E above or below the median is a description, not a judgement on value.